| ASTCT consensus grading for cytokine release syndrome and neurologic toxicity associated with immune effector cells DW Lee, BD Santomasso, FL Locke, A Ghobadi, CJ Turtle, JN Brudno, ... Biology of blood and marrow transplantation 25 (4), 625-638, 2019 | 2166 | 2019 |
| Defining the intensity of conditioning regimens: working definitions A Bacigalupo, K Ballen, D Rizzo, S Giralt, H Lazarus, V Ho, J Apperley, ... Biology of blood and marrow transplantation 15 (12), 1628-1633, 2009 | 1811 | 2009 |
| Lenalidomide after stem-cell transplantation for multiple myeloma PL McCarthy, K Owzar, CC Hofmeister, DD Hurd, H Hassoun, ... New England Journal of Medicine 366 (19), 1770-1781, 2012 | 1325 | 2012 |
| Hematopoietic stem cell transplantation: a global perspective A Gratwohl, H Baldomero, M Aljurf, MC Pasquini, LF Bouzas, A Yoshimi, ... Jama 303 (16), 1617-1624, 2010 | 822 | 2010 |
| Reduced-intensity conditioning regimen workshop: defining the dose spectrum. Report of a workshop convened by the center for international blood and marrow transplant research S Giralt, K Ballen, D Rizzo, A Bacigalupo, M Horowitz, M Pasquini, ... Biology of Blood and Marrow Transplantation 15 (3), 367-369, 2009 | 817 | 2009 |
| Current use of and trends in hematopoietic cell transplantation in the United States A D'Souza, C Fretham, SJ Lee, M Arora, J Brunner, S Chhabra, S Devine, ... Biology of Blood and Marrow Transplantation 26 (8), e177-e182, 2020 | 650 | 2020 |
| Myeloablative versus reduced-intensity hematopoietic cell transplantation for acute myeloid leukemia and myelodysplastic syndromes BL Scott, MC Pasquini, BR Logan, J Wu, SM Devine, DL Porter, ... Journal of Clinical Oncology 35 (11), 1154, 2017 | 603 | 2017 |
| One million haemopoietic stem-cell transplants: a retrospective observational study A Gratwohl, MC Pasquini, M Aljurf, Y Atsuta, H Baldomero, L Foeken, ... The Lancet Haematology 2 (3), e91-e100, 2015 | 455 | 2015 |
| Hematopoietic stem cell transplantation activity worldwide in 2012 and a SWOT analysis of the Worldwide Network for Blood and Marrow Transplantation Group including the global … D Niederwieser, H Baldomero, J Szer, M Gratwohl, M Aljurf, Y Atsuta, ... Bone marrow transplantation 51 (6), 778-785, 2016 | 384 | 2016 |
| Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides, 2010 MC Pasquini, Z Wang | 362 | 2011 |
| Impact of conditioning intensity of allogeneic transplantation for acute myeloid leukemia with genomic evidence of residual disease CS Hourigan, LW Dillon, G Gui, BR Logan, M Fei, J Ghannam, Y Li, ... Journal of Clinical Oncology 38 (12), 1273, 2020 | 331 | 2020 |
| Autologous haemopoietic stem-cell transplantation followed by allogeneic or autologous haemopoietic stem-cell transplantation in patients with multiple myeloma (BMT CTN 0102 … A Krishnan, MC Pasquini, B Logan, EA Stadtmauer, DH Vesole, E Alyea, ... The lancet oncology 12 (13), 1195-1203, 2011 | 331 | 2011 |
| Real-world evidence of tisagenlecleucel for pediatric acute lymphoblastic leukemia and non-Hodgkin lymphoma MC Pasquini, ZH Hu, K Curran, T Laetsch, F Locke, R Rouce, ... Blood advances 4 (21), 5414-5424, 2020 | 329 | 2020 |
| 2010 report from the Center for International Blood and Marrow Transplant Research (CIBMTR): current uses and outcomes of hematopoietic cell transplants for blood and bone … MC Pasquini, Z Wang, MM Horowitz, RP Gale Clinical transplants, 87-105, 2010 | 285 | 2010 |
| A refined risk score for acute graft-versus-host disease that predicts response to initial therapy, survival, and transplant-related mortality ML MacMillan, M Robin, AC Harris, TE DeFor, PJ Martin, A Alousi, VT Ho, ... Biology of Blood and Marrow Transplantation 21 (4), 761-767, 2015 | 275 | 2015 |
| Current use and outcome of hematopoietic stem cell transplantation: CIBMTR Summary Slides MC Pasquini, Z Wang Center for International, Blood & Marrow Transplant Research, 2015 | 271 | 2015 |
| Long-term outcomes after autologous hematopoietic stem cell transplantation for multiple sclerosis PA Muraro, M Pasquini, HL Atkins, JD Bowen, D Farge, A Fassas, ... JAMA neurology 74 (4), 459-469, 2017 | 264 | 2017 |
| Acute graft-versus-host disease: a bench-to-bedside update SG Holtan, M Pasquini, DJ Weisdorf Blood, The Journal of the American Society of Hematology 124 (3), 363-373, 2014 | 264 | 2014 |
| Autologous transplantation, consolidation, and maintenance therapy in multiple myeloma: results of the BMT CTN 0702 trial EA Stadtmauer, MC Pasquini, B Blackwell, P Hari, A Bashey, S Devine, ... Journal of clinical oncology 37 (7), 589, 2019 | 243 | 2019 |
| Increasing use of allogeneic hematopoietic cell transplantation in patients aged 70 years and older in the United States L Muffly, MC Pasquini, M Martens, R Brazauskas, X Zhu, K Adekola, ... Blood, The Journal of the American Society of Hematology 130 (9), 1156-1164, 2017 | 241 | 2017 |
